New device could ease lung pressure in heart failure patients
NCT ID NCT07214376
First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times
Summary
This study tests a device that uses radiofrequency energy to treat high blood pressure in the lungs (pulmonary hypertension) in people with heart failure. The goal is to see if it can reduce serious heart events like hospitalizations or death. About 750 adults with stable heart failure and high lung pressure will be randomly assigned to get the procedure or standard medical care, and they will be followed for up to 3 years.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cardiovascular Institute of the South
RECRUITINGHouma, Louisiana, 70360, United States
-
Oklahoma Heart Institute
RECRUITINGTulsa, Oklahoma, 74104, United States
-
University of Pittsburgh Medical Center
RECRUITINGMechanicsburg, Pennsylvania, 17050, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could continuing a common heart drug before surgery save lives?
- Can better healthcare access save hearts after prison?
- Can a few short nights of sleep tip the scales toward high blood pressure?
- Poles apart? nordic walking may outpace standard rehab for heart failure
- Could a gentler tug on the Heart's reins spark recovery?